GSHD

GSHD

USD

Goosehead Insurance Inc. Class A Common Stock

$102.380+5.050 (5.189%)

Reaalajas hind

Finantsteenused
Kindlustusmaaklerid
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$97.330

Kõrge

$102.670

Madal

$96.880

Maht

0.05M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

3.8B

Tööstusharu

Kindlustusmaaklerid

Riik

United States

Kauplemisstatistika

Keskmine maht

0.30M

Börs

NMS

Valuuta

USD

52 nädala vahemik

Madal $54.8Praegune $102.380Kõrge $130.39

Tehisintellekti analüüsiaruanne

Viimati uuendatud: 29. apr 2025
Tehisintellekti loodudAndmeallikas: Yahoo Finance, Bloomberg, SEC

GSHD: Goosehead Insurance Inc. Class A Common Stock - What's Happening and What to Watch

Stock Symbol: GSHD Generate Date: 2025-04-29 08:06:55

Alright, let's break down what's been going on with Goosehead Insurance (GSHD) based on the latest news and how the stock price has been acting. Think of this as getting the lowdown on the situation.

The Recent News Buzz

Looking at the headlines from April, it's a bit of a mixed picture for Goosehead.

On the positive side, the company announced its first quarter 2025 results. The big takeaway there? Revenue and core revenue both jumped 17% compared to the same time last year. Plus, the total amount of premium they wrote increased by a solid 22%. That sounds like the business itself is growing nicely. They also added a new member to their Board of Directors, which is generally seen as a positive step for governance and expertise.

Now, for the analyst opinions – this is where it gets varied. Several big names like UBS, BMO Capital, JP Morgan, and Piper Sandler all chimed in recently. While some maintained positive ratings like "Buy" or "Overweight," most of them actually lowered their price targets for the stock. For example, UBS went from $145 to $140, BMO from $148 to $142, JP Morgan from $100 to $98, and Piper Sandler from $132 to $122.

But wait, there's a counterpoint! Keefe, Bruyette & Woods maintained their "Outperform" rating and raised their price target from $125 to $130. And JMP Securities stuck with their "Market Outperform" and kept a higher target of $150.

So, the news vibe? The company's operations seem strong based on Q1 numbers, but Wall Street analysts aren't all on the same page about where the stock price should go, with a few notable target reductions mixed in with some maintained positive views and one target increase.

Checking the Price Action

Now, let's look at what the stock price itself has been doing, especially over the last month or so.

If you glance at the historical data, GSHD had a pretty rough ride through April. After trading mostly between $115 and $120 in late March, the price took a noticeable dip starting around the first week of April. It bounced around a bit but saw significant drops, particularly around April 24th and 25th. The price on April 28th closed around $94.56.

Comparing this to the AI's prediction for the very near term: the AI model suggests the price might stay relatively flat today (0.00% change predicted) and then see slight dips over the next couple of days (-0.37% and -0.64%).

So, the stock has been trending downwards recently, especially in April, and the AI thinks that slight downward pressure might continue for a day or two. This recent price drop seems to contrast a bit with the positive Q1 results, suggesting other factors (maybe broader market sentiment or analyst target adjustments) are influencing the price more immediately.

Putting It All Together: Outlook & Ideas

Okay, let's try to make sense of this mix of information.

The company's core business looks healthy with good revenue and premium growth in Q1. That's a fundamental positive. However, the stock price has been falling recently, and several analysts have lowered their price targets, even while keeping positive ratings in some cases. The AI prediction for the immediate future points to potential slight dips.

Given the recent sharp price decline despite the positive Q1 report, and the AI predicting continued slight weakness, the apparent near-term leaning for GSHD seems cautious. It's not screaming "buy" right now based purely on this data, but it's also not a clear "sell" signal across the board, especially with some analysts still maintaining positive views and higher targets. It might be a situation that warrants patience – perhaps a 'hold' for those already in, or a 'watch' for those considering getting in.

If someone were interested in potentially buying, looking at the recent price action, the stock saw significant drops into the low $90s and even high $80s recently. A potential entry consideration might be if the price stabilizes around these recent lows, perhaps in the low-to-mid $90s, or if you see a clear bounce start to form. The AI prediction of downward pressure suggests waiting for stabilization could be wise.

For managing risk, especially given the recent volatility, setting a potential exit or stop-loss consideration is important. The recent low points could serve as a guide. Placing a stop-loss order below the recent lows, maybe somewhere in the high $80s, could help limit potential losses if the downward trend continues unexpectedly. For taking profits, the analyst targets are spread wide, but if the stock starts to recover, watching previous resistance levels or the lower end of the analyst target range (like JP Morgan's $98 or Piper Sandler's $122) could be areas to consider.

Company Context

Just a quick reminder about Goosehead: they're an insurance broker, mainly dealing with personal insurance like homeowners and auto policies. So, their performance is tied to things like insurance demand, policy costs, and their ability to grow their network of agents and franchises. The Q1 growth numbers show they are succeeding on that front right now.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock markets are volatile, and prices can move unpredictably. You should always conduct your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

Seotud uudised

Analyst Upgrades

UBS Maintains Buy on Goosehead Insurance, Lowers Price Target to $140

UBS analyst Brian Meredith maintains Goosehead Insurance with a Buy and lowers the price target from $145 to $140.

Vaata rohkem
UBS Maintains Buy on Goosehead Insurance, Lowers Price Target to $140
Analyst Upgrades

BMO Capital Maintains Market Perform on Goosehead Insurance, Lowers Price Target to $142

BMO Capital analyst Michael Zaremski maintains Goosehead Insurance with a Market Perform and lowers the price target from $148 to $142.

Vaata rohkem
BMO Capital Maintains Market Perform on Goosehead Insurance, Lowers Price Target to $142
Analyst Upgrades

Keefe, Bruyette & Woods Maintains Outperform on Goosehead Insurance, Raises Price Target to $130

Keefe, Bruyette & Woods analyst Tommy McJoynt maintains Goosehead Insurance with a Outperform and raises the price target from $125 to $130.

Vaata rohkem
Keefe, Bruyette & Woods Maintains Outperform on Goosehead Insurance, Raises Price Target to $130
Analyst Upgrades

JP Morgan Maintains Neutral on Goosehead Insurance, Lowers Price Target to $98

JP Morgan analyst Pablo Singzon maintains Goosehead Insurance with a Neutral and lowers the price target from $100 to $98.

Vaata rohkem
JP Morgan Maintains Neutral on Goosehead Insurance, Lowers Price Target to $98
Analyst Upgrades

JMP Securities Reiterates Market Outperform on Goosehead Insurance, Maintains $150 Price Target

JMP Securities analyst Matthew Carletti reiterates Goosehead Insurance with a Market Outperform and maintains $150 price target.

Vaata rohkem
JMP Securities Reiterates Market Outperform on Goosehead Insurance, Maintains $150 Price Target
GlobeNewswire

Goosehead Insurance, Inc. Announces First Quarter 2025 Results

– Total Revenue Increased 17% and Core Revenue* Grew 17% over the Prior-Year Period – – Total Written Premium increased 22% to $1.0 billion over the Prior-Year Period – – Net Income of $2.6

GlobeNewswire

Goosehead Insurance Appoints Bill Wade to Board of Directors

WESTLAKE, Texas, April 17, 2025 (GLOBE NEWSWIRE) -- Goosehead Insurance (NASDAQ:GSHD), a leader in personal lines insurance distribution, is proud to announce the appointment of Bill Wade to its Board of Directors.

Tehisintellekti ennustusBeta

Tehisintellekti soovitus

Langev

Uuendatud kell: 4. mai 2025, 00:53

LangevNeutraalneTõusev

59.5% Kindlus

Risk ja kauplemine

Riskitase3/5
Keskmine risk
Sobib
Mõõdukas
Kauplemisjuhend

Sisenemispunkt

$101.40

Võta kasum

$104.56

Peata kahjum

$94.34

Põhitegurid

RSI 70.9 viitab ülemüüdud tingimustele
PDI 12.4 on MDI 5.0 kohal ADX-iga 26.0, mis viitab tõusutrendile
Praegune hind on tugitasemele ($101.48) äärmiselt lähedal, mis viitab tugevale ostuvõimalusele
Kauplemismaht on 7.6x keskmisest (3,749), mis viitab äärmiselt tugevale ostusurvele
MACD 0.4025 on signaalijoone 0.3417 kohal, mis viitab tõusvale ristumisele

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.